A few report mild breakouts or increased oiliness, especially without concurrent vitamin C use
Reducing overall body fat levels also diminishes these visceral reserves, leading to improved hormonal function in the processthats the selling point of tirzepatide as a hormonal agent, in short
7 PCCA members with clinical services access may contact our Clinical Services team for help with microdosing GLP-1 RAs and other compounding concerns
Tirzepatide users were less likely to experience any major cardiovascular problems following surgery than people not on the drug (roughly 30% lower risk), though the rate of some problems like heart attacks remained roughly the same between the two groups
These conditions have serious risks for both parents and fetuses, including preterm birth, fetal growth restriction, and an elevated risk of cardiovascular disease for mothers
About to start my second bottle